Merck and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19 DARMSTADT, Germany, May 27, 2020 /PRNewswire-AsiaNet/--
-- Company will focus on process development and improvements for manufacturing Baylor's Covid-19 vaccine candidates
Merck, a leading science and technology company, and Baylor College of Medicine, Houston, Texas, USA, today announced an extension of their ongoing collaboration to advance a manufacturing platform to fight Covid-19, designed to accelerate transition to Phase 1 clinical trials.